Phase IISmall Molecule
Compound 61651
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061651
Risk Class
MODERATE
Last Audit
May 25, 2108
Research Abstract
Small Molecule candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Compound 61651 is a small molecule asset inside small molecule innovation track initiatives, optimized for cognitive resilience and neuroprotection.
The dossier currently sits in phase ii with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061651 with updates logged 2108-05-25.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cognitive resilienceNeuroprotection
Nomenclature
CX-61651Small Molecule Program 61651
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061651
- [2] Operations Pulse • Small Molecule innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61651